TEAMSS – Transforming Expanded Access to Maximize Support & Study
TEAMSS – Transforming Expanded Access to Maximize Support & Study
批准号:
10164885
负责人:
George Alexander Mashour
金额:
$93.56万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-23 至 2023-05-31
关键词:
AddressBiologicalBypassCaringClinicalClinical TrialsClinical Trials DesignClinical and Translational Science AwardsCollaborationsDataData CollectionData ElementData ReportingDatabasesDiagnosisEnvironmentEvaluationFoundationsFutureGoalsGuidelinesIndividualInfrastructureInstitutionInstitutional Review BoardsInterventionInvestigationInvestigational DrugsInvestigational TherapiesKnowledgeMedical DeviceMethodsMovementNatureNetwork-basedOutcomePathway interactionsPatient CarePatientsPharmaceutical PreparationsPhysiciansProceduresProcessRare DiseasesRefractory DiseaseReportingResourcesSafetySiteStandardizationStructureTestingTherapeuticTimeTranslational ResearchTranslationsUnited States Food and Drug AdministrationUnited States National Institutes of HealthWorkbaseclinical carecohortdata accessdata sharingimprovedindividual patientinnovationnetwork modelsnovelpatient advocacy grouppatient populationpaymentprogramsprospective
中文摘要
项目摘要
美国食品药品监督管理局(FDA)的扩大使用(EA)计划为以下方面提供了机会:
缺乏治疗选择或不符合临床试验条件的患者可能从
实验性药物、生物制剂和医疗器械的临床使用。这个过程代表了一个最
直接转化形式,因为实验性治疗直接施用于个体
病人需要。然而,EA干预的个体性质,护理环境的筒仓利用
他们,以及缺乏标准化的报告,导致无法作出更广泛的推论安全
或治疗潜力。一种更协调的EA方法,可以实现更大的集成和产出
更可靠的信息对于罕见或难治性疾病患者的护理可能具有变革性。的
NIH临床和转化科学奖(CTSA)联盟是一个理想的网络,以开发创新
通过EA进行监管导航和支持、监督和交付试验用产品的方法。
因此,我们提出了一个基于CTSA的计划,重点是将扩大的可及性转化为最大限度地
支持和研究(TEAMSS)
我们的长期目标是通过改善患者获得
实验疗法通过一个联邦,国家联盟的EA干预。这个目标
一个应用是开发一个基于CTSA的网络,该网络可以展示EA的成功多站点集成
方案,从而传播最佳做法。我们将通过以下方式实现这一目标
具体目标:开发、展示和传播基于网络的扩大获取的最佳实践
为基于队列的扩展访问计划开发网络;
创建一个数据库,以标准化扩展访问数据报告,并开发一系列真实数据。
这些目标的预期结果是表明,基于网络的方法,EA干预和
结果是可行的和有益的。我们还期望完成一项彻底的景观评估
每个TEAMSS中心的EA基础设施,以及成功传播的最佳实践,
适用于整个CTSA联盟。这将产生积极的影响,第一次,
为一个综合的,全国性的方法,以EA,可以改善照顾最脆弱的基础
患者
英文摘要
Project Summary
The Expanded Access (EA) program of the Food and Drug Administration (FDA) provides an opportunity for
patients who either lack therapeutic options or who are ineligible for clinical trials to potentially benefit from the
clinical use of experimental drugs, biologics, and medical devices. This process represents one of the most
immediate forms of translation because an experimental therapy is administered directly to an individual
patient in need. However, the individual nature of EA interventions, the silos of care environments utilizing
them, and the lack of standardized reporting have led to the inability to make broader inferences about safety
or therapeutic potential. A more coordinated approach to EA that can achieve greater integration and yield
more robust information could be transformative for the care of patients with rare or refractory disease. The
NIH Clinical and Translational Science Awards (CTSA) consortium is an ideal network to develop innovative
methods for regulatory navigation and support, oversight, and delivery of investigational products through EA.
We therefore propose a CTSA-based program focused on Transforming Expanded Access to Maximize
Support and Study (TEAMSS).
Our long-term goal is to advance clinical care and translational research by improving patient access to
experimental therapies through a federated, national consortium for EA interventions. The goal of this
application is to develop a CTSA-based network that can demonstrate successful multisite integration of EA
programs, leading to dissemination of best practices. We will pursue this goal by accomplishing the following
specific aims: Develop, demonstrate, and disseminate best practices of network-based Expanded Access
programs across the CTSA consortium; Develop a network for cohort-based Expanded Access programs;
Create a database to standardize Expanded Access data reporting and develop a body of real-world data.
The expected outcome of these aims is to demonstrate that a network-based approach to EA interventions and
outcomes is both feasible and beneficial. We also expect to have achieved a thorough landscape assessment
of EA infrastructure at each TEAMSS hub, as well as the successful dissemination of best practices that are
applicable across the CTSA consortium. This will create a positive impact by, for the first time, creating a
foundation for an integrated, nationwide approach to EA that can improve care for the most vulnerable
patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of preoptic hypothalamus in sleep-dependent cognition after surgery and general anesthesia
-
批准号:10494980
-
项目类别:
-
资助金额:$54.04万
-
财政年份:2022
-
负责人:George Alexander Mashour
-
依托单位:
Role of preoptic hypothalamus in sleep-dependent cognition after surgery and general anesthesia
-
批准号:10686190
-
项目类别:
-
资助金额:$51.69万
-
财政年份:2022
-
负责人:George Alexander Mashour
-
依托单位:
TEAMSS – Transforming Expanded Access to Maximize Support & Study
-
批准号:10414026
-
项目类别:
-
资助金额:$94.68万
-
财政年份:2018
-
负责人:George Alexander Mashour
-
依托单位:
Michigan Institute for Clinical and Health Research (MICHR)
-
批准号:10199208
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2017
-
负责人:George Alexander Mashour
-
依托单位:
Role of the Prefrontal Cortex in the Control of Arousal States
-
批准号:10380066
-
项目类别:
-
资助金额:$38.01万
-
财政年份:2015
-
负责人:George Alexander Mashour
-
依托单位:
Role of the Prefrontal Cortex in the Control of Arousal States
-
批准号:9765454
-
项目类别:
-
资助金额:$38.01万
-
财政年份:2015
-
负责人:George Alexander Mashour
-
依托单位:
Frontoparietal Mechanisms of Anesthetic-induced Unconsciousness
-
批准号:8518394
-
项目类别:
-
资助金额:$28.51万
-
财政年份:2012
-
负责人:George Alexander Mashour
-
依托单位:
Frontoparietal Mechanisms of Anesthetic-induced Unconsciousness
-
批准号:8634122
-
项目类别:
-
资助金额:$29.55万
-
财政年份:2012
-
负责人:George Alexander Mashour
-
依托单位:
Michigan Institute for Clinical and Health Research (MCHR)
-
批准号:9070793
-
项目类别:
-
资助金额:$47.82万
-
财政年份:2012
-
负责人:George Alexander Mashour
-
依托单位:
Frontoparietal Mechanisms of Anesthetic-induced Unconsciousness
-
批准号:8369549
-
项目类别:
-
资助金额:$29.55万
-
财政年份:2012
-
负责人:George Alexander Mashour
-
依托单位:
Michigan Institute for Clinical and Health Research (MCHR)
-
批准号:9070792
-
项目类别:
-
资助金额:$40.14万
-
财政年份:2007
-
负责人:George Alexander Mashour
-
依托单位:
Michigan Institute for Clinical and Health Research (MCHR)
-
批准号:8875089
-
项目类别:
-
资助金额:$14.05万
-
财政年份:2007
-
负责人:George Alexander Mashour
-
依托单位:
Michigan Institute for Clinical and Health Research (MCHR)
-
批准号:8875088
-
项目类别:
-
资助金额:$962.89万
-
财政年份:2007
-
负责人:George Alexander Mashour
-
依托单位:
Core-008
-
批准号:9459244
-
项目类别:
-
资助金额:$14.9万
-
财政年份:--
-
负责人:George Alexander Mashour
-
依托单位:
Core-005
-
批准号:9459241
-
项目类别:
-
资助金额:$211.11万
-
财政年份:--
-
负责人:George Alexander Mashour
-
依托单位:
海外基金